## Objective: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. ## Method: Thirty-nine patients fulfilling dsm-iv-tr diagnostic criteria for schizophrenia and had depressive symptoms were studied in a prospective 6-week open-label design
The effect of quetiapine on aggression and hostility in patients with schizophrenia
β Scribed by Celso Arango; Miguel Bernardo
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 66 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-6222
- DOI
- 10.1002/hup.686
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
A post hoc analysis of data from three placeboβcontrolled, doubleβblind, randomized trials was carried out to determine the efficacy of quetiapine in aggression and hostility in patients with schizophrenia. Quetiapine treatment induced statistically significantly greater improvements in BPRS positive symptom cluster scores and three measures of hostility derived from the BPRS, compared with placebo, in patients symptomatic at baseline. A path analysis showed that the improvements in hostility were highly correlated with improvements in positive symptoms and there was no consistent relationship between sedation and hostility. Aggressive behaviour appears to be related to positive symptoms of schizophrenia. Quetiapine may be a suitable option for patients with schizophrenia and aggressive behaviour. Copyright Β© 2005 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
This analysis of data from the open-label extension (OLE) phases of three randomized clinical trials of quetiapine in patients with schizophrenia (n=415) was undertaken to investigate whether the initial improvements in anxiety and depressive symptoms were maintained during long-term treatment. The
## Abstract Secondβgeneration βatypicalβ antipsychotics appear to be more effective than firstβgeneration βtypicalβ antipsychotics in improving negative symptoms in schizophrenia; it is unclear, however, if this greater improvement represents a direct beneficial effect or is mediated indirectly by
## Abstract Negative symptoms are considered the most debilitating and refractory aspect of schizophrenia, being associated with poor social, occupational and global outcomes. Conventional antipsychotics have limited efficacy against these symptoms and poor tolerability profiles. Atypical antipsych
Recently, several small studies have indicated that quetiapine may be useful in the treatment of drug-induced psychosis in patients with PD. However, there have been questions related to atypical antipsychotic therapy and patient selection and how that may affect response and tolerability, especiall